||Involving patients in the assessment and evaluation of medication treatment|
||Sieta de Vries|
||Petra Denig, Floor Haaijer-Ruskamp, Dick de Zeeuw|
||The first aim of the project is to develop a patient-oriented risk assessment instrument for addressing common, non-serious adverse drug events, and to evaluate the feasibility of implementing the method in trials and post-marketing surveillance. A patient-reported Adverse Drug Event (ADE) questionnaire will be developed and its reliability and validity will be tested in patients with type 2 diabetes mellitus. Qualitative and cross-sectional studies will be used to assess this aim.|
The second aim of is to assess the influence of patients’ medication beliefs, age and life-expectancy on treatment preferences and decisions for preventive medication. A discrete choice experiment will be conducted among patients with type 2 diabetes mellitus.
||3e GS, TI Pharma Escher Project (2.7), 1e GS, SHARE|